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Abstract
Background:  Natural products are an important source of drugs and other commercially
interesting compounds, however their isolation and production is often difficult. Metabolic
engineering, mainly in bacteria and yeast, has sought to circumvent some of the associated
problems but also this approach is impeded by technical limitations. Here we describe a novel
strategy for production of diverse natural products, comprising the expression of an
unprecedented large number of biosynthetic genes in a heterologous host.
Results: As an example, genes from different sources, representing enzymes of a seven step
flavonoid pathway, were individually cloned into yeast expression cassettes, which were then
randomly combined on Yeast Artificial Chromosomes and used, in a single transformation of yeast,
to create a variety of flavonoid producing pathways. Randomly picked clones were analysed, and
approximately half of them showed production of the flavanone naringenin, and a third of them
produced the flavonol kaempferol in various amounts. This reflected the assembly of 5–7 step
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multi-species pathways converting the yeast metabolites phenylalanine and/or tyrosine into
flavonoids, normally only produced by plants. Other flavonoids were also produced that were
either direct intermediates or derivatives thereof. Feeding natural and unnatural, halogenated
precursors to these recombinant clones demonstrated the potential to further diversify the type
of molecules that can be produced with this technology.
Conclusion: The technology has many potential uses but is particularly suited for generating high
numbers of structurally diverse compounds, some of which may not be amenable to chemical
synthesis, thus greatly facilitating access to a huge chemical space in the search for new
commercially interesting compounds
Background
Traditionally, discovery and production of small mole-
cule compounds, including drugs, has been associated
with organic synthetic chemistry. However, most of the
existing drugs on market are derived from natural sources,
either in the form of compounds purified directly from
the source organisms, derivatives of such compounds, or
compounds for which the basic structure was inspired by
natural compounds [1,2]. Natural products are often not
tractable to chemical synthesis and isolation from the nat-
ural source can be difficult, in practice limited to macro-
scopic organisms or species that can be grown or reared in
controlled environments. Despite these problems [3],
exploring microorganisms [4] and plants [5] for natural
compounds is still considered among the best options for
drug discovery and the potential in the area is huge.
The core technologies used to discover and develop active
natural products have not changed significantly over the
past decades. One way to improve the situation is by using
metabolic engineering of microorganisms and some
recent improvements of molecular biology techniques
and combinatorial biosynthesis approaches have resulted
in several examples of heterologous expression of entire
prokaryotic gene clusters. The expression of functional
eukaryotic pathways has been more challenging. Short
eukaryotic pathways have been assembled in bacteria and
yeast, combining genes from different species, mainly
plants [6-9]. These studies have focused on specific path-
ways with one or a few specific genes for each enzymatic
step cloned on plasmid vectors, and have resulted in the
production of a variety of products. Although proven and
straightforward, this cloning strategy has some restrictions
regarding the number of genes that can be introduced and
maintained at the same time in the new host, and in the
limited flexibility for testing several gene combinations
simultaneously.
An increasing number of reports describe the activity of
flavonoids in several therapeutic areas including cancer
[10,11], inflammation [12], cardiovascular disease [13],
Central Nervous System disorders [14], and several others
[15]. Their antiviral and antibacterial activities are also
well documented [16]. This class of plant secondary
metabolites displays a broad range of aromatic structures,
most of which are stable, soluble and UV-active, greatly
facilitating their detection. Flavonoid biosynthetic path-
ways have been assembled in E. coli [17-21] and recently
production of flavonoids was achieved in yeast (S. cerevi-
siae) as well [22,23], in some cases based on precursor
feeding [7,22-24].
Here we present a novel and conceptually different strat-
egy for in vivo synthesis of natural compounds facilitating
access to the chemistry of natural compounds, in particu-
lar from the eukaryotic world. It allows the expression of
large numbers of heterologous genes, and comprises the
option of combining these in a random manner. Using
modified eYACs (expressible Yeast Artificial Chromo-
somes) for expression in yeast (S. cerevisiae), a host which
has several advantages over bacteria for expression of
eukaryotic genes [7,8,22], we were able to assemble sev-
eral different, but related, biosynthetic pathways by a sin-
gle step random approach. The production of diverse
flavonoid compounds was used to demonstrate the
potential of this technology.
Results
Assembly, transformation, and stable replication of eYACs
Gene coding sequences representing enzymes of the flavo-
nol pathway were cloned into Entry vectors between yeast
promoters and terminators (Fig. 1). To allow concerted
regulation of expression, methionine dependent promot-
ers were selected from different Saccharomyces  species.
These had previously been found to exhibit expression
patterns in S. cerevisiae similar to the native MET25 (data
not shown). The terminators were selected randomly
among those commonly used in yeast expression vectors.
After amplification in E. coli, the pool of Entry vectors was
digested with two rare cutting restriction enzymes to
release the expression cassettes from the vector back-
bones. Expression cassettes were then randomly concate-
nated, by ligation, into long chains of high molecular
weight DNA. Subsequently, YAC arms containing telom-
eres, yeast auxotrophic markers, and yeast elements for
replication and segregation were ligated onto the ends ofMicrobial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
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the concatemeric DNA to create linear eYAC molecules.
These eYAC molecules, each with a random combination
of gene expression cassettes, were transformed into yeast
(S. cerevisiae) by spheroplasting and selected for by means
of the auxotrophic markers. The size of eYACs in trans-
formed clones ranged from around 40 Kb to 500 Kb with
an estimated average size of about 130 Kb. Assuming an
average size of 2.5 Kb per expression cassette this corre-
sponds to approximately 50 randomly combined cas-
settes per eYAC. In the majority of clones, eYACs were
visible by simple ethidium bromide staining after gel elec-
trophoresis, indicating relatively stable replication of
these artificial chromosomes, and in all clones eYACs
were easily visualized by DNA hybridization (Fig. 2). Phe-
notypes (flavonoid production) were retained after more
than 50 generations suggesting that eYACs exhibit a level
of stability comparable to normal YACs, in which the
insert is typically a fragment of genomic DNA. For further
confirmation of eYAC integrity, DNA was isolated from
two clones and digested with AscI to release the expression
cassettes. These were re-cloned in E. coli and presence of
the flavonoid genes was verified by DNA sequencing (data
not shown).
Reconstitution of flavonoid pathways
Genes representing the entire flavonol pathway (Fig. 3)
were used to construct the FL1 library. In clones from this
library various amounts of kaempferol, a flavonol, were
detected in 8 out of 24 clone pellets analysed, thus con-
firming assembly of entire functional pathways. In addi-
tion, clones with incomplete pathways were obtained as
indicated by the accumulation of intermediates such as
the flavanone naringenin. More generally, we observed
different expression patterns between clones (Fig. 4), indi-
cating the assembly of pathways with either redundancies
and/or differences in the gene combination on individual
eYACs. Maximum total yields observed, in pellet and
growth medium combined, were 858 μg/L naringenin
and 235 μg/L kaempferol. Also pinocembrin (a fla-
vanone) and dihydrokaempferol (a dihydroflavonol)
were detected in some clones, as well as compounds that
by UV spectra, masses, and MS-MS fragmentation data
Assembly of eYACs Figure 1
Assembly of eYACs. (a) Genes of interest are cloned into Entry vectors and amplified in E. coli. (b) Expression cassettes 
(hatched and white) containing the genes are generated by a double digest of Entry vectors, leaving cassettes with compatible 
sticky ends, while backbone DNA (gray) is left with blunt ends. (c) Cassettes are concatenated by ligation. In parallel, YAC 
arms (checked), supplying all necessary elements for chromosomal function, are prepared by double digest of a pYAC4 deriva-
tive. Both long and short arms have compatible, sticky overhangs at one end and telomeres at the other. The long arm also 
contains a centromere (checked oval) and an autonomous replicating sequence (ARS). Each arm also carries an auxotrophic 
selection marker (long arm TRP1 and short arm LEU2). (d) Arms are ligated to the ends of cassette concatemers to form 
eYACs.Microbial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
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were identified as flavonoids, e.g. several with unexpected
hydroxylation patterns (see Additional file 1). Such com-
pounds are likely to be the result of the combined action
of yeast metabolic and eYAC derived enzymes, as
observed earlier by others [23]. Finally, expression of the
flavonoid genes seems to be accompanied by specific
changes in the host metabolism, leading to the appear-
ance of several new peaks, especially in the later half of the
LC chromatogram. Spectral data for all detected flavonoid
compounds are available online in supplementary data
(see Additional file 1).
Diversification by precursor feeding
A common strategy to expand the structural diversity of
products from a particular biosynthetic pathway is to use
an external supply of molecular building blocks. To
explore this option for expanding our repertoire of flavo-
noids, we prepared an additional eYAC library, FL2, in
which the first steps (PAL and C4H) of the flavonol path-
way were not included, preventing the use of internal
yeast precursors. This would allow flavonoids to be pro-
duced only after feeding with a substrate accepted by the
enzyme 4-coumarate-CoA ligase (4CL). Clones from the
FL2 library were first grown in the presence of coumaric
acid and screened by LC-UV/MS for production of the fla-
vonoids naringenin or kaempferol. One or both of these
compounds were found in about 50% of clones analysed.
A clone containing an approximately 500 Kb eYAC (data
not shown), and producing naringenin and kaempferol
when fed with coumaric acid, was selected for precursor
feeding with various natural and unnatural cinnamic acid
derivatives. With no external substrate this clone did not
produce any detectable flavonoids; but when fed with the
natural precursors cinnamic acid, coumaric acid, caffeic
acid, or umbellic acid, the flavanones and flavonols corre-
sponding to all four precursors were produced (cinnamic
acid yielded pinocembrin and galangin; coumaric acid
yielded naringenin and kaempferol; caffeic acid yielded
eriodictyol and quercitin; and umbellic acid yielded
5,7,2',4'-tetrahydroxy-flavanone and morin) (Fig. 5).
When feeding with the halogenated precursors 4-chloro-
cinnamic acid, 4-bromo-cinnamic acid, and 3-bromo-, 4-
fluoro-cinnamic acid we found the corresponding halo-
genated flavanones in small amounts and, in addition,
trace amounts of other flavonoid compounds (see Addi-
tional file 2 and 3).
Discussion
Our results show that eYACs can be readily used for tar-
geted reconstitution of a particular heterologous pathway
in yeast. Used for this purpose the approach is simple and
rapid, and the outcome to some extent similar to what has
been reported by others, who used more directed cloning
strategies [17,23]. However, the real potential of the eYAC
approach as a metabolic engineering tool lies in the fact
that many different multi-species pathways can be assem-
bled randomly with a single procedure. In the example of
the full flavonol pathways of the FL1 library, genes from
at least three source organisms were required to reach the
end product. It confirms the principle that genes from, in
theory, any organism can be combined to achieve novel
biosynthetic pathways and desired phenotypes.
The eYAC approach allow cloning and expression of large
numbers of genes and, even in comparison to combinato-
rial biosynthesis in bacteria, the number of genes per indi-
Verification of eYACs in flavonoid producing strains Figure 2
Verification of eYACs in flavonoid producing strains. Separation of eYACs and yeast chromosomes by PFGE (left). 
Numbers indicate different clones, and M is the Lambda DNA size marker (BioRad) indicating upward increments of approx. 
50 kb. Settings were optimized for separation in the 50 – 600 kb area. eYACs are visible in the lower part of the gel after ethid-
ium bromide staining. Confirmation of the eYACs by Southern DNA hybridization (right).Microbial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
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The biosynthetic pathways reconstituted on eYACs in the FL1 library included PAL (phenylalanine amonialyase), C4H (cinna- mate 4-hydroxylase), 4 CL (4 coumarate:CoA ligase), CHS (chalchone synthase), CHI (chalchone isomerase), F3H (flavanone  3-hydroxylase), and FLS (flavonol synthase) Figure 3
The biosynthetic pathways reconstituted on eYACs in the FL1 library included PAL (phenylalanine amonial-
yase), C4H (cinnamate 4-hydroxylase), 4 CL (4 coumarate:CoA ligase), CHS (chalchone synthase), CHI (chal-
chone isomerase), F3H (flavanone 3-hydroxylase), and FLS (flavonol synthase). No specific TAL (tyrosine 
ammonialyase) was used, but some PAL enzymes are known to also have this function. For the FL2 library the enzymes PAL 
and C4H were omitted. As shown for cinnamate the phenyl ring can be differently substituted. Cinnamate has hydrogen in all 3 
positions, whereas coumarate has R4 = OH, caffeate has R3 = OH; R4 = OH, and umbelleate has R2 = OH; R4 = OH. Some 
unnatural derivatives, substituted with halogens at the R3 and R4 positions, were also used as precursors in this study.Microbial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
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Yeast clones from the FL1 library exhibit different expression patterns according to the combination of genes on the eYAC, as  illustrated by the UV-chromatograms Figure 4
Yeast clones from the FL1 library exhibit different expression patterns according to the combination of genes 
on the eYAC, as illustrated by the UV-chromatograms. From top to bottom: control with no eYAC (only a plasmid 
with the selection markers TRP1 and LEU2 as for eYACs) followed by clones nos. 1, 31, 41, and 43 with eYACs of approxi-
mately 220 Kb, 130 Kb, 350 Kb, and 60 Kb, respectively (see Fig. 2). Several new UV-peaks appear after introduction of eYACs, 
most notably the naringenin (3.74) and kaempferol (3.79).
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
0.0
2.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
0.0
2.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
0.0
2.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
0.0
2.0e+2
0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00
0.0
2.0e+2
Flav_080620_30
x2 0.76
0.60
1.18
1.06 1.66 2.87
1.75 2.49
Flav_080620_35
x2 0.76 0.61
1.19
1.15 3.79 3.73
1.94 1.66 2.86 2.69 3.67 5.29
5.02 7.91 5.52
5.97 7.13
Flav_080620_40
x2 0.76
0.61
1.17
1.05
1.94
1.65 2.87
3.733.80
Flav_080620_45
x2 3.79 0.76
3.74
1.19
1.07
2.69
2.59 1.661.78
2.87
3.68
5.29
5.03
4.61 4.00
6.48 5.50
6.15 5.59
5.97
7.91 6.70
7.67 6.92 7.50 8.13
Flav_080623_09
x2 0.76
0.60
3.74
2.70 1.94 1.20 1.43 2.59
3.68 5.29 5.03 3.80 4.79 5.53Microbial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
Page 7 of 11
(page number not for citation purposes)
vidual cell that can be expressed in this system is
extraordinarily high. With an average eYACs size of
around 130 Kb, as obtained here, and an average size of
2.5 Kb per expression cassette (assuming coding
sequences of ~1.5 Kb) the calculated number of heterolo-
gous genes corresponds to around 50 genes per molecule.
The metabolic load of expressing such numbers of heter-
ologous genes would potentially put the yeast under con-
siderable stress [25]. However, with the FL1 library we
observed only minor growth retardation, with an average
doubling time during exponential growth increasing from
118 min during non-inducing conditions to 138 min in
medium inducing expression (data not shown). As
known for regular YACs, yeast is able to maintain and rep-
licate a number of such large chromosome sized mole-
cules, both in haploid and diploid cells. Similarly, it
should therefore be possible to maintain more than one
eYAC of the type described here in a haploid cell and, by
mating, obtain diploids with several eYACs, together car-
rying hundreds of heterologous genes. We are currently
exploring these options, and with e.g. 200 or more heter-
ologous genes the issue of metabolic load may have to be
investigated further. Also, spurious recombination
between repeated sequences could become more frequent
with increased numbers of cassettes and probably addi-
tional promoters and terminators will have to be
employed to prevent this from becoming a serious issue.
Several new promoters and terminators have already been
cloned in our laboratory with this purpose (data not
shown).
The amount of public gene sequence information from
both eukaryotes and prokaryotes is increasing rapidly,
and with the advent of cheap commercial gene synthesis
any sequence can be optimized for expression in yeast.
Homologues, and functional analogues, from different
organisms will often have different substrate specificities
and turnover rates. Including several different enzymes in
each catalytic step of a pathway promotes natural selec-
tion of optimized combinations for a given phenotype
and reduces the effect of metabolic bottlenecks. Further,
inclusion of enzymes with additional modifying activi-
ties, would allow biosynthesis of a variety of intermedi-
ates and end products. Finally, the occurrence of
compounds which are not direct intermediates of the
introduced pathway, strongly suggests a contribution
from yeast metabolic enzymes. Altogether, these features
obviously increase the diversity of compounds that can be
created and, along with the option of precursor feeding,
give access to a broad and diverse chemistry space.
Yeast has been extensively used for construction of drug
screening assays, e.g. the yeast two-hybrid model for
receptor/ligand binding or protein/protein interactions
[26]. Assays like these are fully compatible with the intro-
duction of eYACs, offering the possibility for new active
compounds to be produced and detected in the same cell.
For any interesting compound found by such screening,
chemical synthesis may often be the preferred route of
production, but the current approach also offers the
option of identifying and transferring relevant genes to a
more "production-friendly" host strain in which yields
can then be optimized.
Conclusion
We have developed a fast and simple strategy for combin-
ing and assembling large numbers of genes deriving, in
principle, from any kind of species, metabolic pathway, or
functional group of enzymes. The technology is ideal for
generating high numbers of structurally diverse com-
pounds, many of which may not be amenable to chemical
synthesis. By facilitating the exploration of natural prod-
ucts and, at the same time, providing a route to otherwise
inaccessible and possibly unexpected chemistry, this tech-
nology is likely to improve the odds of drug discovery in
the pharmaceutical industry.
Methods
Host strains
All bacterial cloning was performed in E. coli XL10 Gold
super competent cells (Stratagene). The yeast strain used
was a S. cerevisiae BY4742 derivative with the genotype:
MATα, his3Δ1, leu2Δ0, lys2Δ0, trp1Δ, ura3Δ0.
Construction of vectors
For ease of handling, all genes were first cloned in E. coli
vectors having yeast expression cassettes containing i) a
yeast promoter, ii) the gene of interest, and iii) a yeast
transcription termination signal. These Entry vectors were
prepared by first inserting a small synthetic multiple clon-
ing site (MCS) between the two PvuII sites of pBluescript
II KS+ (Stratagene) to create pEVE1. The basic design of
the MCS was SrfI – AscI – BglII – HindIII – SfiI(a) – SfiI(b)
– SacII – SphI – AscI – SrfI (see Additional file 4). The vec-
tors have a 622 bp stuffer fragment between the SfiI sites.
To reduce the number of repeated sequences in the final
YAC expression vectors and, hence, limit the chance of
spontaneous homologous recombination, a mix of Entry
vectors was used, containing all possible combinations of
4 different promoters and 6 different transcription termi-
nators, all deriving from yeast species closely related to S.
cerevisiae. To create the mix of 24 Entry vectors, two MET2
and two MET25 promoters were cloned between BglII and
HindIII and 6 different yeast transcription termination sig-
nals were inserted between SacII and SphI. A list of pro-
moters and terminators is provided in supplementary
data (see Additional file 4) online. The YAC vector used
was based on pYAC4 (GenBank acc. no. U01086), in
which the original URA3 auxotrophic marker gene had
been exchanged with a LEU2 marker gene. Finally, an AscIMicrobial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
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Precursor feeding experiment with a clone from FL2 library containing a truncated flavonoid pathway (see text) on an approx- imately 500 Kb eYAC Figure 5
Precursor feeding experiment with a clone from FL2 library containing a truncated flavonoid pathway (see 
text) on an approximately 500 Kb eYAC. Using natural precursors, a variety of flavonoids are produced including the 
expected flavanone and flavanol. From top to bottom: No precursor; cinnamic acid, yielding pinocembrin (5.26) and galangin 
(5.26); coumaric acid, yielding naringenin (3.84) and kaempferol (3.90); caffeic acid, yielding eriodictyol (3.30) and quercitin 
(3.33); and finally umbellic acid, yielding 5,7,2',4'-tetrahydroxy-flavanone (3.35) and morin (3.02).
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site had been inserted into the unique EcoRI site separat-
ing the two YAC arms. An outline of the vectors is pro-
vided as supplementary online data (see Additional file
5).
Cloning in Entry vectors
Genes representing enzymes of the flavonol pathway (Fig.
3) were selected from a range of plants (parsley, soybean,
maize, thale cress, bishop's weed, morning glory, petunia,
kudzu, tutsan, mandarin orange, strawberry, and rice), a
fungus (Aspergillus), and a yeast (Rhodosporidium). Based
on published sequences the genes were either cloned from
cDNA, prepared using the Mint cDNA synthesis kit from
Evrogen JSC, Moscow, Ru, or they were custom synthe-
sized by commercial suppliers (Codon Devices, MA, USA,
or Epoch Biolabs, TX, USA) and, in this case, codon opti-
mised for expression in yeast. All genes were cloned in a
mix of 24 Entry vectors, between HindIII and SacII, and 3–
5 different clones were selected for each gene. Genomic
DNA from salmon sperm was digested with HindIII and
SphI, and size fractionated by agarose gel electrophoresis
to obtain fragments with an estimated size of 2 – 4 Kb.
These fragments were cloned in HindIII and SphI of an
empty Entry vector (pEVE1) to create a library of genomic
spacer fragments. The S. cerevisiae replication signal
ARSH4 was PCR amplified from pRS413 (GenBank acc.
no. U03447) and cloned in HindIII and SphI of an empty
Entry vector.
Construction of eYACs
After amplification of Entry vectors in E. coli these were
digested with the two rare cutting restriction enzymes AscI
(NEB) and SrfI (Stratagene), generating expression cas-
sette fragments with sticky AscI ends, and vector backbone
fragments with blunt SrfI ends. Entry vectors containing
salmon sperm DNA, and the ARSH4 sequence, were
digested the same way. Reaction mixes of 500 μg total
DNA were set up, for the FL1 library, containing 50 μg
Entry vector of each of the 7 steps in the flavonol pathway,
5 μg ARSH4 vector, and 145 μg of vector with salmon
sperm DNA and, for the FL2 library, containing 50 μg
Entry vector of each of steps 3–7 of the pathway, 5 μg
ARSH4 vector, and 245 μg of vector with salmon sperm
DNA. The specific genes used for all steps are listed in
online supplementary data (see Additional file 6 and 7).
The reactions were incubated o/n with AscI and SrfI, and
the two small spacer fragments between the AscI and SrfI
sites (21/25 bases) were removed by filtration on Micro-
con YM-30 columns (Millipore).
Cassettes were concatenated, favoring the ligation of
sticky ends, by adjusting the reaction to 5 mM ATP (Fer-
mentas), adding T4 ligase (Stratagene) (25 mU/μg DNA
starting material), and incubating for 3 h at RT, yielding
high molecular weight DNA. To create fresh sticky ends
for adding YAC arms, the DNA was then briefly submitted
to a 3 min partial AscI digest (6 mU/μg DNA starting mate-
rial) before adding YAC arm DNA at a w/w ratio of 1:10,
based on starting material of YAC vector and Entry vector,
respectively, and performing a final ligation reaction, all
in the same vial. Arm DNA had been prepared in advance
by an o/n double digest of the YAC vector with AscI and
BamHI followed by dephosphorylation and phenol/chlo-
roform extraction.
Size fractionation of eYACs
To select for molecules in the desired size range for trans-
formation, newly synthesized eYACs were fractionated by
Pulsed Field Gel Electrophoresis (PFGE) on a 1% low
melting agarose gel (SeaPlaque, Lonza) run on a CHEF-
DR III system (BioRad) set at switch angle 120°, switch
time 8 sec, 6.7 Vcm-1 for 16 h at 14°C. Molecules esti-
mated to be above 50 Kb were, thus, concentrated in a
compression zone which was excised and treated with β-
agarase (NEB) to liberate the DNA [27,28]. Without fur-
ther purification, but after estimating the DNA concentra-
tion by gel electrophoresis, the eYAC preparation was
used for transformation of yeast.
Spheroplast transformation
Transformation was done essentially as described by
Green et al. [29], except that 1 L of cells were grown in
YPD to an OD600 of 3–5 of which 3000 OD units (e.g. 1 L
at OD600 = 3) were used for one transformation batch.
Spheroplast formation was monitored by measuring the
reduction of OD600 after dilution in water. Incubation
with Zymolyase-100T (Seikagaku Corp.) was continued
until the OD600 reached 20% of initial density. eYAC DNA
in solution (see above) was added to spheroplasts at a
ratio of max 20% v/v and carefully mixed. Spheroplast
recovery medium was supplemented with uracil, histi-
dine, leucine, tryptophan, adenine, lysine and methio-
nine at 20 mg/L. Transformants were selected on SC-Leu
medium, containing 1 M sorbitol. Nobel agar (Difco), at
2.5%, and CSM-Leu powder (MPBio), were used in the
top agar. Transformants were restreaked as single clones in
SC-Leu-Trp plates before further analysis.
Documentation of eYACs
Yeast clones were grown in medium selective for the YAC
arms and small scale preparations of agarose embedded
chromosomal DNA was prepared using the LIDS proce-
dure [28]. 40 μL agarose embedded DNA, as well as a
lambda DNA size marker (BioRad), were loaded on a 1%
low melting agarose gel and the DNA separated by PFGE
on a CHEF-DR III system (BioRad) set at switch angle
120°C, switch time increasing from 10–40 sec., and 6.7
Vcm-1 for 16 hours at 14°C. The gel was stained with
ethidium bromide and photographed. The DNA was then
nicked by UV-irradiation and transferred under alkalineMicrobial Cell Factories 2009, 8:45 http://www.microbialcellfactories.com/content/8/1/45
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conditions to Zeta-Probe® GT nylon membrane (BioRad),
according to the protocol described in the CHEF-DR III
manual. Southern DNA hybridization analysis was per-
formed using a 500 bp DNA probe specific for the LEU2
marker gene on the short YAC arm, together with a 400 bp
probe specific for the lambda DNA size marker. Probes
were generated using the PCR DIG probe synthesis kit
(Roche). Hybridization was performed according to the
Zeta-Probe® GT Blotting Membranes Standard protocol
and detection was performed using the DIG Luminescent
Detection Kit (Roche).
Flavonoid production
The promoters of expression cassettes were from either
MET2 or MET25 genes to allow concerted induction of all
heterologous genes by growing cells in methionine defi-
cient medium. Yeast pre-cultures were inoculated from
single colonies in SC-Leu-Trp supplemented with 2 mM
methionine, for repression of heterologous gene expres-
sion, and grown for 24 h at 30°C, before being harvested
by centrifugation and resuspended in SC-Leu-Trp-Met to a
concentration of OD600 = 0.1. Cultures of 25 mL were
then grown for 48 – 72 h at 30°C, centrifuged, and cell
pellets were analyzed. In precursor feeding experiments
cinnamic acid, or its derivatives, was added to the growing
culture in five aliquots at 10–14 h intervals, reaching a
final precursor concentration of 0.5 mM, minus what was
consumed during the experiment.
Extraction and LC-MS/MS analysis
Cell pellets, 150 mg, were suspended in 5 mL organic sol-
vent (ethylacetate:dichloromethane:methanol) (3:2:1)
and sonicated 1 h in an ultrasonic bath. Growth media
were extracted in 1 volume of organic solvent. The organic
phases were collected, dried in a SpeedVac® and resus-
pended in 100 μL DMSO. Typically, aliquots of 5 μL were
injected for LC-UV/MS and MS/MS analysis, running a 10
min gradient of mobile phases A (water:acetonitrile
(95:5) + 0.1% formic acid) and B (acetonitrile + 0.1% for-
mic acid), going from 5–100% B. Flow rate: 0.4 mL/min.
Column: BEH C18 (2.1 × 100 mm) 1.7 μm, column tem-
perature 35°C. UV detection between 210 – 400 nm. The
instrument was a Waters Acquity® UPLC- TQD coupled
with a UV Photodiode Array Detector (PDA). LC-UV/ESI/
MS were run in ionisation modes ES+ and ES-, capillary
voltage 3.5 kV, cone voltage 35 V, extractor 3 V, source
temperature 130°C, desolvation temperature 350°C, des-
olvation gas flow 800 mL/min, and cone gas flow 50 mL/
min. Scanning range was m/z 90–750, and scan duration
(time) 0.25 sec. LC-UV/DAD-ESI/MS/MS source parame-
ters were the same as for the MS analysis. Collision gas
was argon, collision gas flow 0.5 mL/min (1.02 × 10-2
mbar), collision energy 20–40 eV, and scan time 0.1 sec.
Additional analytical results are available online (see
Additional file 1, 2, 3, 7, 9, 10, and 11).
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